Get the Stockscreener App
3.0013
2.88%
0.0513
Aurora Cannabis Inc. stock is traded at $3.0013, with a volume of 295.17K.
It is up +2.88% in the last 24 hours and down -8.58% over the past month.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
See More
Previous Close:
$2.95
Open:
$2.95
24h Volume:
295.17K
Relative Volume:
0.31
Market Cap:
$185.83M
Revenue:
$267.06M
Net Income/Loss:
$-69.17M
P/E Ratio:
-2.6546
EPS:
-1.1306
Net Cash Flow:
$-22.38M
1W Performance:
-10.21%
1M Performance:
-8.58%
6M Performance:
-45.12%
1Y Performance:
-50.65%
1-Day Range:
$2.95
$3.04
1-Week Range:
$2.73
$3.43
52-Week Range:
$2.73
$6.665
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
3.00 | 182.73M | 267.06M | -69.17M | -22.38M | -1.1306 |
TAK
Takeda Pharmaceutical Co Adr
|
15.61 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.98 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.15 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.78 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
546.32 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Dec-11-24 | Initiated | TD Cowen | Buy |
| Feb-09-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Aurora Cannabis Inc. stock falls Monday, underperforms market - MarketWatch
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Will Cannabis Stocks on TSX Completion Index Rally on Rate Reset? - Kalkine Media
Aurora Cannabis Is Maintained at Buy by Canaccord Genuity - Moomoo
Aurora Cannabis dips after projecting a revenue decline for FY27 - MSN
Aurora Cannabis Q4 earnings on deck: Here's what to expect - MSN
Aurora Cannabis Price Target Cut to C$8.00/Share From C$10.00 by TD - Moomoo
Aurora Cannabis Is Maintained at Buy by TD - Moomoo
Aurora Cannabis Shares Touch Three-Year Low on Expected Revenue Decline - Moomoo
Aurora Cannabis Inc. stock falls Friday, underperforms market - MarketWatch
Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs - The Globe and Mail
Aurora Cannabis announces full results for 2026 fiscal year - MMJDaily
Aurora Cannabis 4Q Loss Widens on Higher Costs - Moomoo
StockTalk | Cannabis Report: Results, awards, & upgrades | 2026-06-12 | Investing News - Stockhouse
Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To IgnoreBuy (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Aurora Cannabis Inc (ACB) Q4 2026 Earnings Call Highlights: Stro - GuruFocus
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Aurora (ACB) Q4 2026 Earnings Transcript - The Motley Fool
Aurora Cannabis Inc (ACB) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Puff, puff, profit: Aurora Cannabis earns record revenue and adjusted EBITDA | 2026-06-11 | Investing News - Stockhouse
Aurora Cannabis Down 4% in U.S. Pre-Market After It Forecast a Decline in Fiscal Year 2027 Total Net Revenue - Moomoo
Aurora Cannabis Inc. (ACB:CA) Q4 2026 Earnings Call Transcript Summary - Moomoo
Aurora Cannabis Q4 2026 Earnings Call Transcript - MarketBeat
Earnings call transcript: Aurora Cannabis Q4 2026 highlights strong growth By Investing.com - Investing.com Canada
Aurora Cannabis Reports Strong Q4 and Full-Year Results, Stock T - GuruFocus
'Canadian medical products are the highest equity products in the world': Aurora Cannabis CEO - BNN Bloomberg
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quart - GuruFocus
Growing International Sales Not Enough to Offset Canadian Non-Medical Losses for Aurora in FY26 - StratCann
Why Aurora Cannabis Inc stock is plummeting today - Wealth Awesome
Aurora Cannabis (ACB) Reports Strong Q4 Earnings with Revenue Gr - GuruFocus
Aurora Cannabis (ACB) Reports Q4 FY26 Results with Mixed Outlook - GuruFocus
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹ - Investing News Network
Earnings call transcript: Aurora Cannabis Q4 2026 highlights strong growth - Investing.com
Press Release: Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results With Record Annual Revenue and Adjusted EBITDA(1) - Moomoo
Aurora Cannabis Q4 Earnings Call Highlights - MarketBeat
Aurora Cannabis Shares Fall Pre-Bell After Fiscal Q4 Adjusted Net Income Drops - marketscreener.com
Aurora Cannabis FY26 revenue rises 11% to $321 million - scanx.trade
Full Transcript: Aurora Cannabis Q4 2026 Earnings Call - Benzinga
Aurora Cannabis (ACB) Reports Q4 Financial Results and Growth St - GuruFocus
Aurora Cannabis stock dips after Q4 FY26 results (ACB:NASDAQ) - Seeking Alpha
Aurora Cannabis Posts Record FY2026 Medical Revenue, Buys EU-GMP Facility as It Exits Lower-Margin Units - TipRanks
Aurora Cannabis reports record annual revenue, adjusted EBITDA By Investing.com - Investing.com South Africa
Aurora Cannabis reports record annual revenue, adjusted EBITDA - Investing.com
ACB: Q4 FY26 delivered record medical cannabis revenue, strong margins, and global market leadership - TradingView
Canada's Aurora Cannabis Q4 revenue beats estimates - TradingView
Aurora Cannabis : Financial StatementPDF (FS 202631 Q4 2026 Final) - marketscreener.com
Earnings Scheduled For June 11, 2026 - Benzinga
Aurora Cannabis reports record fiscal 2026 revenue of $288.6 million - StreetInsider
Aurora Cannabis (ACB) files 2026 Form 40-F with 58,947,593 shares disclosed - Stock Titan
Aurora Cannabis Inc. Stock (ACB) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):